Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
Intrathecal T-cell clonal expansions in patients with multiple sclerosis.
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Myeloid cells - targets of medication in multiple sclerosis.
Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders.
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis.
Diagnosis and Management of Multiple Sclerosis in Children.
Levels and Rates of Physical Activity in Older Adults with Multiple Sclerosis.
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy.
Vascularized nerve grafts: an experimental study.
Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire.
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Heterogeneous depression trajectories in multiple sclerosis patients.
Commentary on: Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Overview of quantitative susceptibility mapping.
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Neurotropin attenuates local inflammatory response and inhibits demyelination induced by chronic constriction injury of the mouse sciatic nerve.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination.
The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis.
Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein.
Pages
« first
‹ previous
…
735
736
737
738
739
740
741
742
743
…
next ›
last »